Stakeholder Call - Myocarditis and Pericarditis Updates - 6/29/2021

U.S. Food and Drug Administration
U.S. Food and Drug Administration
34,091
0
Published 2021-07-06
Acting FDA Commissioner Janet Woodcock, M.D. and the Director of FDA's Center for Biologics Evaluation and Research, Peter Marks, M.D., Ph.D., discuss the suggested increased risks of myocarditis and pericarditis following #COVID19 vaccination.